ATP6AP1 and cancer: To determine whether ATP6AP1 and ATP6AP2 loss-of-function mutations are pathognomonic for GCTs, we investigated their presence in 6285 non-hypermutated cancers across 14 common cancer types from The Cancer Genome Atlas (TCGA) studies retrieved from the cBioPortal6.